Loading…
Valencell secured financing from strategic investors led by Halma, with participation from existing investors, to accelerate investments in biometric sensor systems and blood pressure technology. Terms were not disclosed.
Valencell and SunTech Medical signed a multi-year collaboration agreement to jointly develop clinical-grade blood pressure solutions augmented with PPG sensor technology.
Valencell, a wearable biometric sensor technology firm, and Sonion, a microacoustic and micromechanical technology company, announced a strategic partnership. Sonion made a strategic investment in Valencell, becoming a significant shareholder.
| Site | Largest | Latest |
|---|---|---|
| United States | 2020-01-27 |